Early reduction of immune activation in lymphoid tissue following highly active HIV therapy

AIDS

Volumn 12, Issue 11, 1998, Pages

  Andersson, Jan ^a,d   Fehniger, Thomas E ^a   Patterson, Bruce K ^b   Pottage, John ^c   Agnoli, Michelle ^c   Jones, Paul ^c   Behbahani, Homira ^a   Landay, Alan ^c  

^a KAROLINSKA INSTITUTE   (Sweden)

^b NORTHWESTERN UNIVERSITY   (United States)

^c RUSH MEDICAL COLLEGE   (United States)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Cytokines; Highly active antiretroviral therapy; HIV coreceptors; Image analysis; Immunopathogenesis; Lymphoid tissue; Viral load

Indexed keywords

ANTIRETROVIRUS AGENT; CALPROTECTIN; CD68 ANTIGEN; CHEMOKINE RECEPTOR; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 1ALPHA; INTERLEUKIN 2; INTERLEUKIN 4; TUMOR NECROSIS FACTOR ALPHA; VIRUS DNA;

ARTICLE; CASE REPORT; CELLULAR DISTRIBUTION; COMPUTER ANALYSIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; IMMUNOSTIMULATION; LYMPHOID TISSUE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROVIRUS; TONSIL; VIRUS IMMUNITY;

EID: 0032581587     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199811000-00004     Document Type: Article

References (24)

1. Gray CM, Morris L, Murray J, et al.: Identification of cell subsets expressing intracytoplasmic cytokines within HIV-1-infected lymph nodes. AIDS 1996, 10:1467-1475.
2. Scarlatti C, Tresoldi E, Bjorndal A, et al.: HIV escapes chemokine control, changes coreceptor usage in parallel. Nature Med 1997, 3:1259-1265.
3. Chun TW, Carruth L, Finzi D, et al.: Quantification of latent tissue reservoirs, total body viral load in HIV-1 infection. Nature 1997, 387:183-188.
4. Ho DD, Neumann AU, Perelson AS, Chen W, Leonard JM, Markowitz M: Rapid turnover of plasma virions, CD4 lymphocytes in HIV-1 infection. Nature 1995, 373:123-126.
5. Cohen OJ, Pantaleo G, Lam GK, Fauci AS: Studies on lymphoid tissue from HIV-infected individuals: implications for the design of therapeutic strategies. Springer Semin Immunopathol 1997, 18:305-122.
6. Connors M, Kovacs JA, Krevat S, et al.: HIV infection induces changes in CD4+ T-cell phenotype, depletions within the CD4+ T-cell repertoire that are not immediately restored by antiviral or immune-based therapies. Nature Med 1997, 3:533-540.
7. Finzi D, Hermankova M, Pierson T, et al.: Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. Science 1997, 278:1295-1300.
8. Haase AT, Henry K, Zupancic M, et al.: Quantitative image analysis of HIV-1 infection in lymphoid tissue. Science 1996, 274:985-989.
9. Cavert W, Notermans DW, Staskus K, et al.: Kinetics of response in lymphoid tissues to antiretroviral therapy of HIV-1. Science 1997, 276:960-964.
10. Patterson BK, Jiyamapa D, Mayrand E, et al.: Detection of HIV-1 DNA in cells, tissue by fluorescent in situ 5′-nuclease assay (FISNA). Nucleic Acids Res 1996, 24:3656-3658.
11. Andersson J, Abrams J, Björk L, et al.: Concomitant in vivo production of 19 different cytokines in human tonsils. Immunology 1994, 83:16-24.
12. Björk L, Fehniger T, Andersson U, Andersson J: Computerized assessment of production of multiple human cytokines at the single-cell level using image analysis. J Leukocyte Biol 1996, 59:287-295.
13. Litton M, Dohlsten M, Rosendahl A, et al.: The functional significance of a collaboration between CD4+, CD8+ T cells in generating a successful cytotoxic anti-tumor attack. Am J Pathol 1997, 150:1607-1618.
14. Salazar-Gonzalez JF, Martinez-Maza O, Aziz N, et al.: Relationship of plasma HIV-RNA levels, levels of TNF-alpha, immune activation products in HIV infection. Clin Immunol Immunopathol 1997, 84:36-45.
15. Than S, Hu R, Oyaizu N, et al.: Cytokine pattern in relation to disease progression in human immunodeficiency virus-infected children. J Infect Dis 1997, 175:47-56.
16. Navikas V, Link J, Persson C, et al.: Increased rnRNA expression of IL-6, IL-10, TNF-alpha, perform in blood mononuclear cells in human HIV infection. AIDS Res Hum Retrovirus 1995, 15:484-489.
17. McKenzie SW, Dallalio G, North M, Frame P, Means Jr RT: Serum chemokine levels in patients with non-progressing HIV infection. AIDS 1996, 10:F29-F33.
18. Graziosi C, Pantaleo G, Gantt KR, et al.: Lack of evidence for the dichotomy of TH1, TH2 predominance in HIV-infected individuals. Science 1944, 265:248-252.
19. Shearer GM, Clerici M: Protective immunity against HIV infection: has nature done the experiment for us? Immunol Today 1996, 17:21-24.
20. Loetscher P, Uguccioni M, Bordoli L, et al.: CCR5 is characteristic of Th1 lymphocytes. Nature 1998, 391:344-345.
21. Perelson AS, Essunger P, Cao Y, et al.: Decay characteristics of HIV-1-infected compartments during combination therapy. Nature 1997, 387:188-191.
22. Pakker NG, Noremans DW, Boer RJ, et al.: Biphasic kinetics of peripheral blood T cells after triple combination therapy in HIV-1 infection: a composite of redistribution and proliferation. Nature Med 1998, 4:208-214.
23. Autran B, Carcelain G, Li TS, et al.: Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease. Science 1997, 277:112-116.
24. Tenner-Racs K, Stellbrink H-J, van Lunzen J, et al.: The unenlarged lymph nodes of HIV-1-infected, asymptomatic patients with high CD4 T-cell counts are sites for virus replication and CD4 cell proliferation. The impact of highly active antiretroviral therapy. J Exp Med 1998, 187:949-959.